Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Biomark Health Oy
OY
Active
Y-tunnus 3349657-5
Biokatu 12, 33520
Tampere
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2023 · 3 years old
— employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biomark Health Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Income statement
EUR thousands
Item
2024
2025
Revenue
55
53
Staff expenses
18
−18
EBITDA
98
5
Depreciation & amort.
—
—
EBIT
12
5
Net financials
—
0
Profit before tax
12
5
Tax
2
−1
Net profit
10
4
Balance sheet
EUR thousands
Item
2024
2025
Total assets
46
46
Equity
36
38
Long-term debt
—
—
Short-term debt
9
8
Total debt
9
8
Financial ratios
5-year trend
EBITDA margin
9.6%
This company
15.8%
Market median
-39% vs market
2024
2025
Equity ratio
83.0%
This company
38.2%
Market median
+117% vs market
2024
2025
Return on equity
11.2%
This company
18.4%
Market median
+39% vs market
2024
2025
Net profit margin
8.0%
This company
8.1%
Market median
-1% vs market
2024
2025
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
2024
2025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
More on Biomark Health Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
